These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 28443096)

  • 1. The Microbiota and Epigenetic Regulation of T Helper 17/Regulatory T Cells: In Search of a Balanced Immune System.
    Luo A; Leach ST; Barres R; Hesson LB; Grimm MC; Simar D
    Front Immunol; 2017; 8():417. PubMed ID: 28443096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysbiosis of gut microbiota induced the disorder of helper T cells in influenza virus-infected mice.
    Yu B; Dai CQ; Chen J; Deng L; Wu XL; Wu S; Zhao CL; Jiang ZY; Chen XY
    Hum Vaccin Immunother; 2015; 11(5):1140-6. PubMed ID: 25874358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.
    Geurts L; Neyrinck AM; Delzenne NM; Knauf C; Cani PD
    Benef Microbes; 2014 Mar; 5(1):3-17. PubMed ID: 23886976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota in health and disease: an overview focused on metabolic inflammation.
    Nagpal R; Kumar M; Yadav AK; Hemalatha R; Yadav H; Marotta F; Yamashiro Y
    Benef Microbes; 2016; 7(2):181-94. PubMed ID: 26645350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Th17 Cells in Type 1 Diabetes: Role in the Pathogenesis and Regulation by Gut Microbiome.
    Li Y; Liu Y; Chu CQ
    Mediators Inflamm; 2015; 2015():638470. PubMed ID: 26843788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Special Relationship in the Development and Function of T Helper 17 and Regulatory T Cells.
    Lochner M; Wang Z; Sparwasser T
    Prog Mol Biol Transl Sci; 2015; 136():99-129. PubMed ID: 26615094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prebiotic effects: metabolic and health benefits.
    Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
    Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiota, inflammation and obesity.
    Sanz Y; Moya-Pérez A
    Adv Exp Med Biol; 2014; 817():291-317. PubMed ID: 24997040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B lymphocytes, the gastrointestinal tract and autoimmunity.
    Zouali M
    Autoimmun Rev; 2021 Apr; 20(4):102777. PubMed ID: 33609796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetics, microbiota, and intraocular inflammation: New paradigms of immune regulation in the eye.
    Wen X; Hu X; Miao L; Ge X; Deng Y; Bible PW; Wei L
    Prog Retin Eye Res; 2018 May; 64():84-95. PubMed ID: 29357307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting gut microbiota as a possible therapy for diabetes.
    He C; Shan Y; Song W
    Nutr Res; 2015 May; 35(5):361-7. PubMed ID: 25818484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance of gut homeostasis by the mucosal immune system.
    Okumura R; Takeda K
    Proc Jpn Acad Ser B Phys Biol Sci; 2016; 92(9):423-435. PubMed ID: 27840390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of probiotics and gut microbiota on Th17 cells.
    Tanabe S
    Int Rev Immunol; 2013; 32(5-6):511-25. PubMed ID: 24094077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiota and epigenetic regulation of inflammatory mediators in type 2 diabetes and obesity.
    Remely M; Aumueller E; Jahn D; Hippe B; Brath H; Haslberger AG
    Benef Microbes; 2014 Mar; 5(1):33-43. PubMed ID: 24533976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
    Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
    World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The gut microbiota and Type 1 Diabetes.
    Gülden E; Wong FS; Wen L
    Clin Immunol; 2015 Aug; 159(2):143-53. PubMed ID: 26051037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota.
    Peterson CT; Sharma V; Elmén L; Peterson SN
    Clin Exp Immunol; 2015 Mar; 179(3):363-77. PubMed ID: 25345825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroenteric axis modulates the balance of regulatory T cells and T-helper 17 cells in the mesenteric lymph node following trauma/hemorrhagic shock.
    Morishita K; Coimbra R; Langness S; Eliceiri BP; Costantini TW
    Am J Physiol Gastrointest Liver Physiol; 2015 Aug; 309(3):G202-8. PubMed ID: 26045612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis.
    Tojo R; Suárez A; Clemente MG; de los Reyes-Gavilán CG; Margolles A; Gueimonde M; Ruas-Madiedo P
    World J Gastroenterol; 2014 Nov; 20(41):15163-76. PubMed ID: 25386066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.